Pharmaceutical Industry 2021
The author of the report analyzed that the global Pharmaceutical Industry accounted for US$ 1350.29 billion in 2017. Chronic conditions such as diabetes, depression, asthma and hypertension are increasing. The companies use FDA-regulated information to inform physicians and patients about new medicines in advance of a prescribing decision. Direct-to-consumer advertising also help in increasing the demand for a particular drug.
Growth opportunities for pharma companies are expected to increase in next few years, as many drugs are going off-patent in the US and other countries, which is increasing competition. Digital Health Knowledge Resources, Electronic Medical Record, Mobile Healthcare, Electronic Health Record, Hospital Information System and PRACTO are some of the technologies gaining wide acceptance in the sector. Pharmaceutical Industry is facing unprecedented challenges caused by slower sales growth, shorter product life cycles, tighter regulations, expiring patents, increasing competition from generics, adverse media coverage and reputational damage, and a decline in the number of new innovative drugs under development. However, due to increasing population and income levels, demand for high-end drugs is expected to rise.
Access Full Report Details and Order this Premium Report @ https://www.absolutemarketsinsights.com/reports/Pharmaceutical-Market-2018-2026-33
Major Key Players:
Some of the key participants in global market are Abbott, AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Baxter, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc, Merck & Co., Inc, Novartis AG, Pfizer, Inc., Sanofi and Teva Pharmaceutical Industries Ltd.
Key findings of the report:
Among the drug type, prescription drug is a dominant segment holding the largest market share. Existence of government-protected “monopoly” rights for drug manufacturers is driving the prescription drugs. In 2015, the US pharmaceutical industry spent $5.2 billion on advertising prescription drugs directly to consumers.
This sector is characterized by an extensive Research and Development (R&D) infrastructure and a comprehensive talent pool. It has an appropriate scientific regulatory system, and an advanced environment for fostering investments in new drug discovery and development. In the United States, R&D investments of the companies have grown consistently over the past 15 years. The U.S. Pharmaceutical Industry is the world’s most important national market with a number of top global companies from the United States.
Market Segmentation
Pharmaceutical Industry – By API Type
Synthetic API
Biotech API
Pharmaceutical Industry – By Drug Type
Prescription Drugs
OTC Drugs
Market By Customer Base Type
Generic Drugs
Branded Drugs
Pharmaceutical Industry – By Application Type
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Gastrointestinal Disorders
Nephrology
Ophthalmology
Others
Market By Region
North America
U.S.
Rest of North America
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Southeast Asia
Rest of Asia Pacific
Middle East and Africa
GCC Countries
Southern Africa
Rest of Middle East and Africa
Latin America
Brazil
Rest of Latin America
Contact us:
Shreyas Tanna
Phone: +91-740-024-2424
Absolute Markets Insights
